Citius Pharmaceuticals, Inc.

CTXRNASDAQ Capital Market·USD·Closed

CTXRNASDAQ·USD·Closed

$0.57

−9.81%

$0.57

−$0.06 (9.81%)

52W Range

6thpctl

Volume

0.49×avg

Mkt Cap

6.37MUSD

P/E

-0.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

6thpctl

Volume

0.49×avg

Market Cap

6.37MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-1041.4%

ROIC-75.2%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-128.1×

Current ratio0.58×